GH

Guardant Health INC

-$1.0B

Net Activity

Institutions Holding

484

Popularity Rank

#1153

Avg Weight

0.24%

Total Value

$12.6B

Ownership Trend

484 institutions currently hold GH, with 251 net buyers and 241 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

241

Net Buying Institutions

251

Key Holders

Key Holders

Top 5 by Value

BI
BlackRock, Inc.
$1.1B
PT
Price T Rowe Associates INC /md/
$648.8M
VP
Vanguard Portfolio Management LLC
$539.3M
VC
Vanguard Capital Management LLC
$519.5M
IL
Invesco Ltd.
$456.9M

Top 5 by Conviction

CC
Cadian Capital Management, LP
8.77%
DT
Deep Track Capital, LP
5.04%
EA
Eventide Asset Management, LLC
3.61%
SP
Summit Partners Public Asset Management, LLC
3.01%
EA
Emerald Advisers, LLC
2.46%
View all 484 holding institutions

Quarterly Activity

Recent Activity

+$7.5B

Total Buy Value

$6.1B

Total Sell Value

New buy61
Trim161
Add190
Sold out80

251

Net Buyers

241

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

15

Filings (90d)

$57.11M

Total Est. Value

399K shares

Planned Shares

Last Filed 2026-07-01
FilerFiling DateEst. Value
Joyce Meghan V.2026-07-01$660K
Talasaz AmirAli2026-06-26$39.21M
Joyce Meghan V.2026-06-26$300K
Joyce Meghan V.2026-06-24$280K
POTTER MYRTLE S2026-06-22$204K
Tariq Musa2026-06-22$256K
Joyce Meghan V.2026-06-22$813K
Tariq Musa2026-06-16$15K
Kalia Kumud2026-06-15$445K
Kalia Kumud2026-06-15$79K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding GUARDANT HEALTH INC (GH)?
Major stakeholders currently include BlackRock, Inc. ($1.1B), Price T Rowe Associates INC /md/ ($648.8M), Vanguard Portfolio Management LLC ($539.3M). Based on the latest 13F filings, there are a total of 484 tracked investment funds and institutions maintaining positions in GH.
What is the overall institutional sentiment toward GH recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $1.0B, driven by 251 managers accumulating shares while 241 reduced their exposure.
Which institutions have been selling or reducing their GH positions?
In the latest period, 161 funds trimmed their holdings, and 80 managers completely exited their positions. The aggregate reported sell value was $6.1B.
Are there any notable investors adding GH to their portfolios?
Yes, buying activity remains notable. 61 institutions opened new positions in {ticker}, and 190 existing holders added to their shares. The total reported buy value for the quarter amounted to $7.5B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,603

Total reported value

$438.8B

402 institutions currently hold both GH and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,337

Total reported value

$730.5B

436 institutions currently hold both GH and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

4,024

Total reported value

$283.9B

400 institutions currently hold both GH and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail